soul trial oral semaglutide cardiovascular outcomes trial SOUL: Bests Usual Care in High-Risk Type 2 Diabetes Oral Semaglutide's Impact on Cardiovascular

It belongs to a class of medications called GLP-1 receptor agonists, which work by stimulating insulin release in response to meals, reducing glucagon secretion, and slowing gastric emptying all of which help control blood sugar levels in adults with type 2 diabetes

In this comprehensive, data-driven analysis, we will break down the science, the trial results, delivery mechanisms like the Retatrutide pen, and the side-effect profiles to determine which peptide reigns supreme

Artichoke extract is included to help promote bile flow and healthy fat processing in the liver

Your esophagus is highly sensitive

Zepbound 10 mg and 12 mg were out of stock in 4 of the last 8 weeks

Major adverse cardiovascular events were also lower in patients on a GLP-1 RA (14.9% vs 18.5%